Probiotic Innovation in Menopause: Expert Perspectives and Clinical Evidence
06 Nov 2025 | AB-BIOTICS Kaneka Probiotics
As the demand for science-backed, non-hormonal solutions in menopause care continues to grow, consumer health companies face increasing pressure to bring clinically credible products to market.
This webinar will explore how a precision three-strain probiotic—developed by AB-BIOTICS and Kaneka Probiotics—addresses this need with targeted action on the estrobolome, a key regulator of estrogen metabolism.
The program will cover two key areas: the estrobolome as a novel target in menopause care, with practical guidance on probiotic use, and the clinical evidence supporting Gyntima® / KABP® Menopause, including new clinical trial data.
Designed for professionals in pharmaceutical and consumer health companies, this 45-minute session blends scientific rigor with real-world application.
The agenda is structured to provide a comprehensive overview, from foundational science to clinical evidence and commercial opportunities, and will conclude with a live Q&A.

Franco Vicariotto
Prof

Jolanda van Hal
Senior Journalist Nutrition Insight

Marta Perez
AB BIOTICS

Franco Vicariotto
Prof

Jolanda van Hal
Senior Journalist Nutrition Insight

Marta Perez
AB BIOTICS
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Top Nutrition Trends 2027
Nutrition Insight
















